Meteneprost
- Level
- Commodity
- Parent
- 51182200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51182213This classification denotes a prostaglandin analogue with the molecular formula C23H38O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 269EB4R1TV, chemically known as 9-methylene-11r,15s-dihydroxy-16,16-dimethyl-5z,13e-prostadienoic acid but generally known as meteneprost, which bears US NIH Compound Identifier 5283060. European Medicines Agency schedules Meteneprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08822MIG. The term METENEPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). METENEPROST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule meteneprost under HS 29375000 and SITC 54156. As of Q4 2014, METENEPROST remains the US FDA Preferred Term for this commodity. Meteneprost bears US NLM identifiers UMLS ID C0127783 and NCI Concept Code C90926. SMILES: OC1C(C(C(=C)C1)C/C=C\CCCC(=O)O)/C=C/C(O)C(CCCC)(C)C.
Same parent
Under 51182200 · 23Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.